## Abstract Understanding the process of wound healing will provide valuable insight for the development of new strategies to treat diseases associated with improper regeneration, such as blindness induced by corneal scarring. Heparan sulfate proteoglycans (HSPG) are not normally expressed in the c
Nuclear and cytoplasmic localization of different basic fibroblast growth factor species
โ Scribed by M. Renko; N. Quarto; T. Morimoto; D. B. Rifkin
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 783 KB
- Volume
- 144
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
โฆ Synopsis
The subcellular distribution of basic fibrobla5tic growth factor (bFGF) was analyzed by subcellular fractionation and iinmunofluorescence to gain insight into potential mechanisms for its release from cells. Subcellular fractionation of either SK-Hep-I cells or NIH 3T3 cells transfected with a bFGF cDNA revealed that the 18 kd form of bFGF was found primarily in the cytosolic fraction, whereas the 22 and 24 kd forms of bFGF were found preferentially in ribosomal and nuclear fractions. Analysis of bFGF distribution by imrnunofluorescence using an antibody that recognized all forms of bFCF indicated both cytoplasmic and nuclear localization but failed to reveal any growth factor in structures representing secretory vesicles. Therefore, bFCF has a distribution inconsistent with that of a secretory protein.
๐ SIMILAR VOLUMES
The basic fibroblast growth factor (FGF) is a potent mitogen that has vascular endothelium as one of its principle target cells. Recent work has provided both the complete amino acid sequence of basic FGF and the nucleotide sequence of the genes for both human and bovine basic FGF. Although capillar
## Abstract ## BACKGROUND The authors recently reported that nuclear accumulation of basic fibroblast growth factor (bFGF) demonstrated a significant correlation with recurrence of pituitary adenomas. The current study sought to determine whether nuclear bFGF accumulation was a predictor of surviv
Institute for Diabetes and Endocrinology, La lolla, California 92(1.?7 Treatment of Swiss 3T3 fibroblasts with basic fibroblast growth factor (bFGF) lead to a rapid reduction in epidermal growth factor (EGF) binding and a slower inhibition of EGF receptor autophosphorylation. The reduction in bindi